Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
2(18%)
Results Posted
43%(3 trials)

Phase Distribution

Ph phase_2
2
18%
Ph not_applicable
8
73%
Ph phase_3
1
9%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
1(9.1%)
N/ANon-phased studies
8(72.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(7)
Other(2)

Detailed Status

Completed7
Recruiting2
Suspended1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (18.2%)
Phase 31 (9.1%)
N/A8 (72.7%)

Trials by Status

suspended19%
recruiting218%
completed764%
unknown19%

Recent Activity

2 active trials
Showing 5 of 11
recruitingnot_applicable

Stroke and CPAP Outcome Study 3 Randomized Controlled Trial

NCT06722755
recruitingphase_2

Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial

NCT07060638
completednot_applicable

Stroke and CPAP Outcome Study 3

NCT06029959
suspendedphase_3

Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders

NCT03344419
completedphase_2

Glutamatergic Modulation of Disordered Alcohol Use

NCT02539511
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT06722755Not Applicable

Stroke and CPAP Outcome Study 3 Randomized Controlled Trial

Recruiting
NCT07060638Phase 2

Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial

Recruiting
NCT06029959Not Applicable

Stroke and CPAP Outcome Study 3

Completed
NCT03344419Phase 3

Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders

Suspended
NCT02539511Phase 2

Glutamatergic Modulation of Disordered Alcohol Use

Completed
NCT00183599Not Applicable

Gambling and Brief Interventions

Completed
NCT00685724Not Applicable

A Pilot SMART Design for Pathological Gamblers

Completed
NCT01828307Not Applicable

Exercise: Addressing Stress in Relapse Prevention for Substance Use Disorders

Completed
NCT01969461Not Applicable

Comparing the Effectiveness of Two Alcohol+Adherence Interventions for HIV+ Youth

Unknown
NCT00251173Not Applicable

Project Health Link: Connecting Patients With Services

Completed
NCT00596960Not Applicable

Study of the Effects of Motivational Enhancement Therapy on Alcohol Use in Chronic Hepatitis C Patients

Completed

All 11 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
11